Schedule 13D ownership disclosure

THESEUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 88369M101

Event date: 2024-01-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-24-000664
Form type
SC 13D/A
Filer
TANG CAPITAL PARTNERS LP
CIK
CIK 1191935
Filed
Jan 12, 2024
Reporting period
Jan 09, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub